Management will host a conference call and webcast today at
"Third quarter revenue grew from a year ago as
Operational Highlights & Recent Developments
Hancock Regional Hospital : Added an Arrive Point™ at theParkway Building , expanding the existing deployment and contributing to sequential revenue growth in the third quarter.- Ottonomy Robots: Announced an agreement to deploy up to 50 ground robots at Arrive Point™ locations, and a strategic equity investment in Ottonomy to support integration.
- AP3 Plus Launch: Available for shipping since
October 7 , adding edge computing and on-board vision for package detection and chain of custody tracking. - Partnerships: Signed a nonbinding letter of intent with
LifeSpan Pharmacy to explore a drone pharmacy delivery program, partnered withDXC Technology to bring Arrive Point™ technology into large manufacturing campuses, partnered with Modovolo on automated drone delivery, and began early discussions withPurdue University about testing Arrive Point™ technology with robot platforms on campus. These initiatives remain exploratory and carry no revenue commitments. - Defense Division: Established under Chief Strategy Officer
Neerav Shah to explore military, defense and national security applications, extending the potential market forArrive AI's core technology while maintaining its focus on commercial delivery. - Commercial Office Deployment: Installed two AP3+ Arrive Point™ units in
Central Indiana , the first Arrive Point™ installation in a commercial office building.
Q3 2026 Financial Highlights
- Revenue totaled
$39,700 for the third quarter, compared with$7,450 in the third quarter of 2025, primarily due to an expanded deployment withHancock Hospital . - Total operating expenses were
$3.3 million for the third quarter, compared with$1.7 million in the third quarter of 2025. General and administrative expenses were$3.0 million , compared with$1.4 million . - Net loss was
$3.7 million for the third quarter, compared with$4.4 million in the third quarter of 2025. - Cash and cash equivalents were
$1.1 million and investments at fair value were$1.0 million atSeptember 30, 2026 , compared with cash and cash equivalents of$2.1 million and no investments atDecember 31, 2025 .
Earnings Call Details
- Title:
Arrive AI Inc. Q3 2026 Earnings Call - Date:
November 13, 2026 - Time:
8:30 AM EDT (Live Event) - Webcast Link: https://edge.media-server.com/mmc/p/2bb2cpjt
A replay of the call will be available after the event on
About Arrive AI
Arrive AI (NASDAQ:ARAI) is building the infrastructure for autonomous logistics through a network of intelligent delivery endpoints that enable secure, asynchronous exchange of goods. The company's platform supports drones, ground robotics, and human couriers, solving the "last inch of the last-mile" challenge across logistics, healthcare, and enterprise delivery.
Forward-Looking Statements
This news release and statements of Arrive AI's management in connection with this release or related events may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events and expected business and financial performance and often include words such as "expects," "anticipates," "intends," "plans," "believes," "potential," "will," "should," "could," "would," "optimistic," or "may," and similar expressions. These statements are based on information available as of the date of this release and reflect management's current views and assumptions. They are not guarantees of future performance and involve known and unknown risks, uncertainties, and other factors that may be beyond the company's control. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this release. Potential investors should review Arrive AI's Registration Statement and other filings, including risk factors, available at the U.S. Securities and Exchange Commission website at www.sec.gov. Arrive AI undertakes no obligation to update forward-looking statements to reflect events or circumstances after the date of this release, except as required by law.
Media Contact
Tasha Jones, Marketing Communications Manager, Arrive AI, media@arriveai.com
Investor Contact
Alliance Advisors IR, ARAI.IR@allianceadvisors.com
ARRIVE AI INC.
CONDENSED STATEMENTS OF OPERATIONS (Unaudited)
| Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended | |||||||||||||
Revenue | $ | 39,700 | $ | 7,450 | $ | 69,325 | $ | 98,175 | ||||||||
General and administrative | 2,973,570 | 1,370,346 | 11,232,487 | 6,739,384 | ||||||||||||
Research and development | 272,820 | 179,854 | 976,434 | 564,585 | ||||||||||||
Sales and marketing | 56,687 | 107,530 | 240,101 | 164,793 | ||||||||||||
Total operating expenses | 3,303,077 | 1,657,730 | 12,449,022 | 7,468,762 | ||||||||||||
Interest expense | (140,057 | ) | (283,586 | ) | (655,403 | ) | (452,843 | ) | ||||||||
Other income | 45,070 | 23,388 | 373,738 | 83,454 | ||||||||||||
Change in fair value of derivative liabilities | (274,164 | ) | 896,266 | 948,658 | 1,086,266 | |||||||||||
Accretion of debt discount | (134,137 | ) | (88,295 | ) | (514,052 | ) | (116,033 | ) | ||||||||
Loss on conversion of convertible notes payable | (298,510 | ) | (3,295,072 | ) | (12,340,920 | ) | (3,295,072 | ) | ||||||||
Realized gain on investments | 171,538 | 46,491 | 494,356 | 46,491 | ||||||||||||
Unrealized gain (loss) on investments | 224,437 | (76,120 | ) | (36,539 | ) | (76,120 | ) | |||||||||
Loss on disposal of fixed assets | - | - | (5,974 | ) | - | |||||||||||
Total other income (expenses) | (405,823 | ) | (2,776,928 | ) | (11,736,136 | ) | (2,723,857 | ) | ||||||||
Net loss before taxes | (3,669,200 | ) | (4,427,208 | ) | (24,115,833 | ) | (10,094,444 | ) | ||||||||
Provision for income taxes | - | - | - | - | ||||||||||||
Net loss | $ | (3,669,200 | ) | $ | (4,427,208 | ) | $ | (24,115,833 | ) | $ | (10,094,444 | ) | ||||
Net loss per share, basic and diluted (restated for the 1-for-48 reverse split) | $ | (3.37 | ) | $ | (6.39 | ) | $ | (25.03 | ) | $ | (15.37 | ) | ||||
Weighted-average common shares outstanding, basic and diluted | 1,090,114 | 692,615 | 963,385 | 656,565 | ||||||||||||
CONDENSED BALANCE SHEETS (Unaudited)
Cash and cash equivalents | $ | 1,052,554 | $ | 2,104,004 | ||||
Investments at fair value | 965,504 | - | ||||||
Accounts receivable, net of allowance | 31,805 | 4,975 | ||||||
Inventory | 49,655 | - | ||||||
Prepaid expenses | 375,009 | 189,878 | ||||||
Other current assets | 12,325 | 12,325 | ||||||
Total current assets | 2,486,852 | 2,311,182 | ||||||
Property and equipment, net | 826,185 | 514,684 | ||||||
Right of use assets, operating leases | 1,827,590 | 2,117,284 | ||||||
Patents, net | 270,547 | 272,097 | ||||||
Deferred offering costs | 3,453,767 | 5,650,185 | ||||||
Other assets | 317,226 | 65,633 | ||||||
TOTAL ASSETS | $ | 9,182,167 | $ | 10,931,065 | ||||
Accounts payable | 175,820 | 183,993 | ||||||
Accrued expenses | 1,210,170 | 538,234 | ||||||
Operating lease liability, current | 427,472 | 392,950 | ||||||
Derivative liabilities | 524,977 | 1,460,000 | ||||||
Convertible note payable, net of discount and issuance costs | 3,200,097 | 4,144,657 | ||||||
Note payable, current | 13,660 | 9,140 | ||||||
Total current liabilities | 5,552,196 | 6,728,974 | ||||||
Operating lease liability, long term | 1,403,075 | 1,725,073 | ||||||
Note payables, net of current portion | 28,244 | 1,418 | ||||||
Total liabilities | 6,983,515 | 8,455,465 | ||||||
Common stock | 11,066 | 6,841 | ||||||
Additional paid-in capital | 55,050,358 | 31,215,698 | ||||||
Accumulated deficit | (52,862,772 | ) | (28,746,939 | ) | ||||
Total stockholders' equity | 2,198,652 | 2,475,600 | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | 9,182,167 | $ | 10,931,065 | ||||
CONDENSED STATEMENTS OF CASH FLOWS (summary, nine months, Unaudited)
| Nine Months Ended | Nine Months Ended | |||||||
Net cash used in operating activities | $ | (9,744,919 | ) | $ | (5,048,431 | ) | ||
Net cash used in investing activities | (999,411 | ) | (2,036,474 | ) | ||||
Net cash provided by financing activities | 9,692,880 | 7,772,302 | ||||||
Net increase (decrease) in cash and cash equivalents | (1,051,450 | ) | 687,397 | |||||
Cash and cash equivalents, beginning of period | 2,104,004 | 129,318 | ||||||
Cash and cash equivalents, end of period | $ | 1,052,554 | $ | 816,715 | ||||
SOURCE:
View the original press release on ACCESS Newswire